beta
APHB
AmpliPhi Biosciences Corporation
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
Actual EPS |
---|
Consensus EPS |
Estimated EPS |
Number of Estimates |
EPS Surprise |
Stats
Summary
Ampliphi Biosciences Corp is a biotechnology company engaged in the discovery, development and commercialization of novel phage therapeutics. The Company's pipeline is based on the use of bacteriophages.
Market Cap: 14.7 Million
Primary Exchange: NYSE American
Website: http://www.ampliphibio.com
Shares Outstanding: 13.5 Million
Float: 13 Million
Dividend: 0.0 (0.0%)
Beta: 3.189582
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 2423 trading days
From: 2013-07-24 To: 2019-05-09
Lowest Point:
Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
---|
Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
---|---|---|---|---|---|---|
2017-04-25 | 10.0 | 1.0 | 10.0 | |||
2015-08-07 | 50.0 | 1.0 | 50.0 |